Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial).

Saved in:
Bibliographic Details
Title: Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial).
Authors: Post CCB; Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands; Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: c.c.b.post@lumc.nl., Westermann AM; Medical Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Boere IA; Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Witteveen PO; Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Ottevanger PB; Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Sonke GS; Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lalisang RI; Department of Internal Medicine, Division Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Putter H; Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., Meershoek-Klein Kranenbarg E; Surgery, Leiden University Medical Center, Leiden, the Netherlands., Braak JPBM; Surgery, Leiden University Medical Center, Leiden, the Netherlands., Creutzberg CL; Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bosse T; Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kroep JR; Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Source: Gynecologic oncology [Gynecol Oncol] 2022 May; Vol. 165 (2), pp. 223-229. Date of Electronic Publication: 2022 Mar 11.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1095-6859
DOI:10.1016/j.ygyno.2022.02.025